A new trial suggests GLP-1 weight-loss drugs such as semaglutide could also curb heavy alcohol use. Researchers report weekly injections halved heavy drinking days among adults with alcohol use disorder. Because the same medicine is already used for obesity, the findings could translate into a new treatment pathway for millions, pending further research.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
